257 related articles for article (PubMed ID: 17481742)
1. The anti-papillomavirus activity of human and bovine lactoferricin.
Mistry N; Drobni P; Näslund J; Sunkari VG; Jenssen H; Evander M
Antiviral Res; 2007 Sep; 75(3):258-65. PubMed ID: 17481742
[TBL] [Abstract][Full Text] [Related]
2. Lactoferrin inhibits human papillomavirus binding and uptake in vitro.
Drobni P; Näslund J; Evander M
Antiviral Res; 2004 Oct; 64(1):63-8. PubMed ID: 15451180
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of HSV cell-to-cell spread by lactoferrin and lactoferricin.
Jenssen H; Sandvik K; Andersen JH; Hancock RE; Gutteberg TJ
Antiviral Res; 2008 Sep; 79(3):192-8. PubMed ID: 18456345
[TBL] [Abstract][Full Text] [Related]
4. Heparin-interacting sites of bovine lactoferrin are involved in anti-adenovirus activity.
Di Biase AM; Pietrantoni A; Tinari A; Siciliano R; Valenti P; Antonini G; Seganti L; Superti F
J Med Virol; 2003 Apr; 69(4):495-502. PubMed ID: 12601757
[TBL] [Abstract][Full Text] [Related]
5. Bovine lactoferrin prevents the entry and intercellular spread of herpes simplex virus type 1 in Green Monkey Kidney cells.
Ammendolia MG; Marchetti M; Superti F
Antiviral Res; 2007 Dec; 76(3):252-62. PubMed ID: 17881064
[TBL] [Abstract][Full Text] [Related]
6. Bovine lactoferrin and lactoferricin interfere with intracellular trafficking of Herpes simplex virus-1.
Marr AK; Jenssen H; Moniri MR; Hancock RE; Panté N
Biochimie; 2009 Jan; 91(1):160-4. PubMed ID: 18573311
[TBL] [Abstract][Full Text] [Related]
7. Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein.
Chien YJ; Chen WJ; Hsu WL; Chiou SS
Virology; 2008 Sep; 379(1):143-51. PubMed ID: 18640695
[TBL] [Abstract][Full Text] [Related]
8. Anti herpes simplex virus activity of lactoferrin/lactoferricin -- an example of antiviral activity of antimicrobial protein/peptide.
Jenssen H
Cell Mol Life Sci; 2005 Dec; 62(24):3002-13. PubMed ID: 16261265
[TBL] [Abstract][Full Text] [Related]
9. Bovine lactoferrin peptidic fragments involved in inhibition of Echovirus 6 in vitro infection.
Pietrantoni A; Ammendolia MG; Tinari A; Siciliano R; Valenti P; Superti F
Antiviral Res; 2006 Feb; 69(2):98-106. PubMed ID: 16386316
[TBL] [Abstract][Full Text] [Related]
10. Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface.
Andersen JH; Jenssen H; Sandvik K; Gutteberg TJ
J Med Virol; 2004 Oct; 74(2):262-71. PubMed ID: 15332275
[TBL] [Abstract][Full Text] [Related]
11. Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes.
Ikeda M; Sugiyama K; Tanaka T; Tanaka K; Sekihara H; Shimotohno K; Kato N
Biochem Biophys Res Commun; 1998 Apr; 245(2):549-53. PubMed ID: 9571193
[TBL] [Abstract][Full Text] [Related]
12. Glycosaminoglycans are not indispensable for the anti-herpes simplex virus type 2 activity of lactoferrin.
Marchetti M; Ammendolia MG; Superti F
Biochimie; 2009 Jan; 91(1):155-9. PubMed ID: 18534197
[TBL] [Abstract][Full Text] [Related]
13. Lactoferricin but not lactoferrin inhibit herpes simplex virus type 2 infection in mice.
Shestakov A; Jenssen H; Nordström I; Eriksson K
Antiviral Res; 2012 Mar; 93(3):340-5. PubMed ID: 22269645
[TBL] [Abstract][Full Text] [Related]
14. Bovine lactoferrin peptidic fragments involved in inhibition of herpes simplex virus type 1 infection.
Siciliano R; Rega B; Marchetti M; Seganti L; Antonini G; Valenti P
Biochem Biophys Res Commun; 1999 Oct; 264(1):19-23. PubMed ID: 10527833
[TBL] [Abstract][Full Text] [Related]
15. Variation in antimicrobial activity of lactoferricin-derived peptides explained by structure modelling.
Farnaud S; Patel A; Odell EW; Evans RW
FEMS Microbiol Lett; 2004 Sep; 238(1):221-6. PubMed ID: 15336425
[TBL] [Abstract][Full Text] [Related]
16. Enhanced antitumour activity of 15-residue bovine lactoferricin derivatives containing bulky aromatic amino acids and lipophilic N-terminal modifications.
Eliassen LT; Haug BE; Berge G; Rekdal O
J Pept Sci; 2003 Aug; 9(8):510-7. PubMed ID: 12952392
[TBL] [Abstract][Full Text] [Related]
17. Synthetic porcine lactoferricin with a 20-residue peptide exhibits antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans.
Chen HL; Yen CC; Lu CY; Yu CH; Chen CM
J Agric Food Chem; 2006 May; 54(9):3277-82. PubMed ID: 16637685
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory activity of bovine lactoferrin against echovirus induced programmed cell death in vitro.
Tinari A; Pietrantoni A; Ammendolia MG; Valenti P; Superti F
Int J Antimicrob Agents; 2005 May; 25(5):433-8. PubMed ID: 15848300
[TBL] [Abstract][Full Text] [Related]
19. Microbicidal action of lactoferrin and lactoferricin and their synergistic effect with metronidazole in Entamoeba histolytica.
León-Sicairos N; Reyes-López M; Ordaz-Pichardo C; de la Garza M
Biochem Cell Biol; 2006 Jun; 84(3):327-36. PubMed ID: 16936803
[TBL] [Abstract][Full Text] [Related]
20. The effect of bovine lactoferrin and lactoferricin B on the ability of feline calicivirus (a norovirus surrogate) and poliovirus to infect cell cultures.
McCann KB; Lee A; Wan J; Roginski H; Coventry MJ
J Appl Microbiol; 2003; 95(5):1026-33. PubMed ID: 14633031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
